Before IL-23 was discovered, IL-12 was thought to be one of the principal causes of inflammatory disease and autoimmunity [203], but after the work of Oppmann et al. [204], a new biological model showed how IL-23 was mainly driven in psoriasis, arthritis, and immuno-bowel diseases. Here, IL23A is linked to psoriasis.